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Nature displays a remarkable ability to carry out site-selective post-translational modification of 
proteins, therefore enabling a dramatic increase in their functional diversity1. Inspired by this, chemical 
tools have evolved for the synthetic manipulation of protein structure and function, and have become 
essential to the continued advancement of chemical biology, molecular biology and medicine. However, 
the number of chemical transformations suitable for effective protein functionalization is limited 
because the stringent demands inherent to biological systems preclude the applicability of many 
potential processes2. Put simply, these chemical transformations often need to be selective at a single site 
on a protein, proceed with very fast reaction rates, operate under biologically ambient conditions and 
should provide homogeneous products with near perfect conversion2-7. While many elegant 
bioconjugation methods exist at cysteine, lysine and tyrosine, we reasoned that a method targeting a less 
explored amino acid would significantly expand the protein functionalization toolbox. Herein, we report 
the development of a multifaceted-approach to protein functionalization based on chemoselective 
labelling at methionine residues. By exploiting the unique electrophilic reactivity of a bespoke 
hypervalent iodine reagent, one can target the S-Me group in the side-chain of methionine. The 
bioconjugation reaction is fast, selective, operates at low µM concentrations and is complementary to 
existing bioconjugation strategies. Moreover, the new reaction produces a protein conjugate that is, 
itself, a high energy intermediate with reactive properties that can serve as a platform for the 
development of secondary, visible-light mediated bioorthogonal protein functionalization processes. 
Taken together, the merger of these approaches provides a versatile platform for the development of 
distinct transformations that can deliver versatile, information-rich protein conjugates directly from the 
native biomacromolecules. 
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The sheer structural diversity of the proteome in any single organism means that no one protein 
functionalization method is likely to provide a universal solution for the preparation of protein constructs (Fig. 
1a)8-11. Although encoded by the AUG start codon at the beginning of protein synthesis, methionine is often 
post-translationally excised and thus has a low abundance in proteins (around 2%). It is also frequently used 
as a replacement for hydrocarbon-containing residues12. The limited function of methionine compared to other 
residues, being mainly responsible for protection against oxidative stress, means that its functionalization is 
less likely to impair protein function13. Targeting Met would not only provide a distinct bioconjugation 
approach but also, using our strategy, the resulting Met conjugates provide exploitable intrinsic reactivity such 
that they could lead to the rapid synthesis of diverse, functional protein constructs from native proteins.  
 
To date, the only effective method for bioconjugation at methionine was recently reported by Chang et al, who 
showed that the oxidation of thioethers with oxaziridine reagents provided the basis for an elegant bio-inspired 
strategy to form stable protein-bound sulfoximines14. We aimed to target the polarizable thioether on the Met 
side chain with a suitable electrophile to form a cationic sulfonium species, selectively installing a versatile 
payload and distinct functionality at a methionine residue, thereby providing a fundamentally different 
bioconjugation approach (Figure 1a)8-11. Methionine residues react with cyanogen bromide (CNBr), however, 
such a process cannot function as a bioconjugation method because the reactivity of the resulting unstable 
cyano-substituted sulfonium cation triggers protein backbone cleavage15. Conversely, methionine residues 
undergo slow S-alkylation reactions using iodoacetamide or with other benzyl-derived electrophiles to form 
relatively stable trialkyl sulfonium cations16-19. Striking a balance between the stability of the protein-bound 
sulfonium cations, compatibility of reaction conditions and the reaction rate of the thioether with suitable 
electrophiles has, to date, precluded the development of an effective alkylation-based method for 
bioconjugation at methionine. Guided by these limitations, we posited that a distinct class of electrophile, based 
on the hypervalent iodine scaffold (l-3-iodanes)20, could make for a functioning bioconjugation process at 
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methionine. Tailoring the substituents and counteranion on the I(III) atom should allow tuning of the reactivity 
of the polarizable I(III) nodal center to dovetail with the electron lone pair of the thioether and, also, the stability 
of the resulting sulfonium conjugate through modulation of the electronic features of the groups directly 
attached to the cationic sulfur motif. We had noted that a structurally remarkable iodonium salt (1 in Figure 1, 
R=Et and X=OTf) reacts rapidly with dimethylsulfide (the simplest possible mimic of the thioether motif in 
methionine) to form a sulfonium adduct21,22. Successful reaction of this iodonium salt with methionine would 
not only represent a distinct method for bioconjugation, but also deliver a high-energy conjugate equipped with 
reactive ‘on protein’ groups that could serve as a basis for designing new transformations towards diversely-
functionalized protein constructs (Figure 1b). 
 
 
Figure 1. The evolution of a methionine-selective protein functionalization strategy (a) Existing protein functionalization tactics, 
and the potential for methionine-selective bioconjugation; R = peptide or protein, R1 = various organic groups, R2 = aryl or ester 
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group (b) Functionalized hypervalent iodine reagents enable methionine-selective protein modification, leading to methionine-based 
bioorthogonal protein diversification. X = leaving group; R3 = functional payload. 
 
We first examined the reaction between dipeptide 2a and iodonium triflate 1a (Figure 2a). We observed the 
formation of the desired sulfonium-conjugate 3a, though it was clear from the low yield (27%) that the 
iodonium salt displayed poor stability in aqueous solution. By tailoring the aryl group of the iodonium salt (to 
the electron-deficient 2,4-difluorobenzene) and replacing the triflate counteranion with tetrafluoroborate (1b), 
we found that a readily prepared reagent 1b displayed superior physical properties (half-life in water is > 50 
h). Treatment of reagent 1b with dipeptide 2a gave 70% of the desired product 3b accompanied by the 
corresponding sulfoxide (not shown) after reaction for 30 minutes. 
 
Moving to a more complex substrate, the GLP-1 receptor agonist, exenatide (Byetta™, 2b, a 39-residue helical 
polypeptide containing a single mid-chain methionine, Figure 2b), we found that treatment of a 100 µM 
aqueous solution with 1b led to decomposition of the polypeptide. A key breakthrough revealed that the 
addition of a low concentration of thiourea (20 mM) resulted in a dramatic improvement of the reaction, such 
that sulfonium-conjugate 4a was formed with 68% conversion in less than 2 minutes, accompanied by non-
specific oxidation and labelling. Further improvements could be made by running the reaction in the presence 
of TEMPO (10 mM), which minimized formation of oxidative by-products. Addition of aqueous formic acid 
solution (5 mM, approximately pH 3) reduced the non-specific labelling by-products to trace levels. Finally, 
we found that the labelling process proceeded effectively when conducted in distilled water. Routine analysis 
of ESI-MS and MS-MS fragmentation data confirmed selective reaction at methionine. Although the 
concentration of thiourea is well below the levels needed for protein denaturation, we were pleased to observe 
that the CD spectra of exenatide-conjugate 4a confirmed retention of the characteristic helical structure (See 
the supplementary information S35 for details). While we are not yet certain of the remarkable role of thiourea, 
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it is important to note its presence appears to be fundamental in providing a bioconjugation process at reaction 
rates needed for transformation on complex biomolecules. With these refined conditions, the thiourea-
accelerated bioconjugation was almost instantaneous at exenatide concentrations ranging from 5-500 µM 
without compromising the conversion, and a larger, milligram-scale reaction enabled purification of conjugate 
4a by semi-preparative HPLC to give 79% yield of isolated product. Given the similarity of the exenatide 
conjugate to the intermediate that would arise from reaction of the polypeptide with cyanogen bromide (leading 
to peptide cleavage), it is remarkable that 4a has a half-life in water of over 100 hours. In comparison to the 
corresponding reaction of methionine residues with cyanogen bromide, we believe that the observed stability 
of 4a is a result of the ethyl diazoacetate motif imparting a lesser electron-withdrawing effect on the sulfonium 
salt (than the cyano-group), which in turn leads to a species that is less reactive to attack by the proximal 
carbonyl group and is, hence, a more stable conjugate. 
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Figure 2. Evolution of a methionine-selective bioconjugation strategy. (a) Initial results for functionalization at methionine with 
hypervalent iodine reagents. (b) Optimal process for the thiourea-accelerated methionine selective bioconjugation of exenatide. 
 
The optimized conditions, using 1b, were used to evaluate the substrate scope (Figure 3a). Random coil 
polypeptides that contain methionine, such as AviptadilÔ and tetracosactide, are efficiently converted to the 
sulfonium-conjugates 5 and 6 respectively. GTP-binding protein fragment-Ga, which contains a free 
sulfhydryl group in a N-terminal cysteine residue, underwent smooth methionine-labelling to 7 with 
concomitant oxidative disulfide formation. Teriparatide, a polypeptide containing two methionines, was 
converted to its bis-sulfonium conjugate (8) with good conversions. α-Lactalbumin, a globular protein 
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displaying a readily oxidized methionine residue, undergoes bioconjugation to 9 with minimal competitive 
oxidation. Aprotinin (Trasylol) also forms the corresponding sulfonium-conjugate 10 in good yield. 
Particularly significant is the observation that two cysteine-disulfide linkages within the structure of aprotinin 
(and the labelling to 7) are not affected by 1b, with a single methionine-derived conjugate obtained in high 
conversion. When the methionine residues are buried within the tertiary structure of the protein, for example 
with RNA-ase B, the bioconjugation did not occur, highlighting an inherent selectivity for the labeling process 
between exposed and inaccessible thioether groups. This feature is highlighted by the case of ubiquitin; the N-
terminal methionine residue has only moderate surface exposure and could slow down the rate of 
functionalization to the point where oxidation becomes competitive. Accordingly, reaction under de-
oxygenated conditions allowed for efficient conversion to the labeled product (85%), with a 10:1 
label:oxidation ratio (11). The methionine-selective bioconjugation strategy effectively functionalizes a range 
of polypeptides and proteins in high conversion at µM concentrations and in very short reaction times. Given 
the reactive appearance of 1b – a carbon-electrophile displaying two of the best leaving groups known to 
organic chemists – it is remarkable that this species selectively engages the moderately nucleophilic methionine 
residue in the presence of competitively nucleophilic and oxidizable amino acid residues. Bioconjugation 
strategies that target other amino acids should, therefore, be compatible with, and complementary to, our 
methionine-functionalization process. To exemplify this, we showed that the GTP-binding protein fragment-
Ga could be first labelled at cysteine, using a maleimide derivative,23 and then conjugated at methionine using 
iodonium salt 1b to form 12. The methionine-selective process does not interfere with the cysteine-maleimide 
motif, which itself contains a thioether linkage, thereby highlighting possible applications towards multi-site 
heterolabelling of proteins24. 
 
The modular synthesis of the hypervalent iodine reagents enables facile incorporation of different acyl groups 
attached to the diazo motif, allowing the transfer of a range of functional payloads to proteins (Figure 3b). 
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Functional groups relevant to other bioorthogonal reactions are readily tolerated in both the reagent synthesis 
and methionine labelling, smoothly affording sulfonium-conjugates 4b,c with 80-95% conversion to product. 
Biochemical reporter groups, such as myristyl- and fluorescein-derived esters 4d and 4e, are also readily 
transferred to exenatide. Interestingly, we found that sulfonium-conjugates of exenatide (such as 4f) underwent 
reaction with the tertiary phosphine TCEP, a standard biochemical reagent, resulting in the cleavage of the 
labelling group and return of the parent exenatide 2b in >90% conversion (Figure 3c)25; the cleavage reaction 
also works for conjugates 5, 6, and 8 in comparable conversions and provides a stimulus-responsive means of 
reversing the bioconjugation reaction.  
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Figure 3. Scope of the methionine-selective bioconjugation strategy. (a) Range of polypeptide/protein substrates. (b) Functionalized 
iodonium reagents compatible with the bioconjugation. (c) A stimuli responsive strategy for reversing methionine bioconjugation.  
 
Next, we turned our attention to exploring the multifaceted reactivity that we anticipated would be intrinsic to 
the high-energy methionine-derived conjugate. The electrophilicity of the diazo sulfonium-conjugate 4 
prompted us to investigate the single electron transfer (SET) chemistry of this reactive motif enabled by visible 
light photocatalysis26,27. Addition of a single electron to the diazo sulfonium conjugate 4 could result in 
intermediate 15, which upon cleavage of the C–N2 bond would form a putative radical ylide 15’ (Figure 4a). 
We envisaged two pathways through which we could exploit the reactivity of the previously unexplored radical 
ylide intermediate. Firstly, combining the radical ylide with photo-activated Hantzsch ester 13* (from 13) may 
lead to a reduction process resulting in the generation of a trialkylsulfonium motif, which would impart 
enhanced chemical stability to the protein-conjugate. Furthermore, deployment of a C-4 benzylated Hantzsch 
ester derivative (14, an established precursor for a benzyl radical)28 to intercept the radical ylide species would 
lead to a C–benzylation product that could be used to introduce functional diversity to the protein-conjugate. 
We screened a range of photocatalysts under visible light conditions. When 3c was irradiated with a 30 W lamp 
in the presence of fac-Ir(ppy)3 and the Hantzsch ester 1329,30, we observed the formation of the reduced 
trialkylsulfonium product 17a in 95% yield (determined by 1H NMR, Figure 4b)35. Using these conditions, we 
showed that a range of sulfonium-protein conjugates, including exenatide, glucagon and thioredoxin 
derivatives are reduced, with excellent conversions, to stable trialkylsulfonium species (17b-e, see the 
supplementary information S119 for details). Interestingly, reduction of a thioredoxin-derivative31 to its 
trialkylsulfonium-protein congener 17e proceeds in high conversion without affecting its labile disulfide 
linkage, serving to highlight the mild nature of this protocol. Additionally, the methionine bioconjugation and 
photoreduction steps can be carried out in a one pot operation, significantly simplifying the overall process 
without compromising the yield or purity of the trialkylsulfonium product. 
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Figure 4. Exploiting the multi-faceted reactivity of the protein-sulfonium conjugate. (a) A photocatalytic design plan for secondary 
protein diversification. (b) A system for photo-redox mediated reduction of the sulfonium conjugate and examples of the substrate 
scope; in the case of 17e, further reduction of C–S bond in 13 was not observed35. Interestingly, the reduction of 13 proceeds in light, 
without the Ir-photocatalyst, but the yield was greatly diminished. (c). Secondary protein functionalization via photoredox radical 
cross coupling between diazo sulfonium-protein conjugate and C-4 substituted Hantzsch ester. 
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In testing the viability of the proposed C–benzylation using a modified Hantzsch ester derivative28, we were 
delighted to find that treatment of the exenatide-sulfonium conjugate 4b with o-tolyl Hantzsch ester derivative 
14a, under slightly modified photocatalytic conditions, led to cross-coupling and the formation of the C-
ligation product 18a in high conversion. This unique bioorthogonal protein functionalization reaction not only 
represents the first example of a synthetic radical-radical cross-coupling using a protein scaffold, but also 
provides a platform for bioorthogonal protein diversification wherein two distinct functionalities could be 
introduced sequentially at the same amino acid residue. 
 
In summary, through the merger of methionine-selective bioconjugation and a new visible-light mediated 
photocatalytic reaction platform, information-rich synthetic constructs can be rapidly assembled by a two-step 
protocol directly from native proteins. The remarkable reactivity inherent to the methionine conjugate 
distinguishes the bioconjugation process from other methods. Moreover, the capacity for functional 
diversification, by tailoring the hypervalent iodine reagent and modified Hantzsch ester derivative, means that 
highly functional protein conjugates could be made readily available directly from native proteins.  
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